Zajusz A, Wojcieszek Z
Otolaryngol Pol. 1989;43(4):256-60.
127 patients with pharyngeal cancer were irradiated in the years 1970-1979 with telecobalt-60 in total doses of 60-65 Gy. In the group with not advanced pharyngeal cancer 34% of patients survived during 5 years without any symptoms of neoplasm. In the group with advanced pharyngeal cancer and lymph nodes metastases the 5 years survival was within 15%. The 5-years survival depended mainly upon the extensiveness of the neoplasm. The therapeutic results were influenced also by the age of the patient; 35% were above 60 years of age and 17.3% died before the 5 years period without any symptoms of cancer.
1970年至1979年间，127例咽癌患者接受了钴-60远距离放疗，总剂量为60 - 65戈瑞。在非晚期咽癌组中，34%的患者存活5年且无任何肿瘤症状。在晚期咽癌伴淋巴结转移组中，5年生存率在15%以内。5年生存率主要取决于肿瘤的范围。治疗结果也受患者年龄的影响；35%的患者年龄在60岁以上，17.3%的患者在5年期限前死亡且无任何癌症症状。
